or Try an Advanced Search...

    Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 45.53 3.01% 1.33
    SWTX closed up 3.01 percent on Friday, April 26, 2024, on 84 percent of normal volume.
    Earnings due: May 2
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical SWTX trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    20 DMA Resistance Bearish 3.01%
    Outside Day Range Expansion 3.01%
    Gapped Down Weakness 3.01%
    20 DMA Resistance Bearish 4.96%
    MACD Bullish Signal Line Cross Bullish 4.96%
    Inside Day Range Contraction 4.96%
    20 DMA Resistance Bearish 3.48%
    Jack-in-the-Box Bearish Bearish Swing Setup 6.16%
    Older End-of-Day Signals for SWTX ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 18 hours ago
    Rose Above Previous Day's High about 18 hours ago
    Up 2% about 18 hours ago
    Up 1% about 19 hours ago
    Rose Above 20 DMA about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SWTX Chart by TradingView
    Basic chart:

    Profile

    Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development

    Is SWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear
    Apr 24 SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Apr 19 SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners
    Apr 18 SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
    Mar 4 SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN
    Feb 29 SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
    Feb 27 SpringWorks Therapeutics Inc (SWTX) Reports Q4 and Full Year 2023 Financial Results
    Feb 27 SpringWorks Therapeutics GAAP EPS of -$5.15 misses by $0.23, revenue of $5.45M
    Feb 27 SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
    Feb 22 SpringWorks Therapeutics to Present at Upcoming Investor Conferences
    See more SWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.92
    52 Week Low 18.0
    Average Volume 1,070,273
    200-Day Moving Average 34.40
    50-Day Moving Average 47.59
    20-Day Moving Average 44.02
    10-Day Moving Average 43.26
    Average True Range 2.51
    RSI (14) 51.69
    ADX 21.68
    +DI 17.63
    -DI 23.52
    Chandelier Exit (Long, 3 ATRs) 44.68
    Chandelier Exit (Short, 3 ATRs) 46.42
    Upper Bollinger Bands 47.18
    Lower Bollinger Band 40.87
    Percent B (%b) 0.74
    BandWidth 14.33
    MACD Line -1.01
    MACD Signal Line -1.32
    MACD Histogram 0.3028
    Fundamentals Value
    Market Cap 3.28 Billion
    Num Shares 72.1 Million
    EPS -4.87
    Price-to-Earnings (P/E) Ratio -9.35
    Price-to-Sales 74.50
    Price-to-Book 8.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 49.43
    Resistance 3 (R3) 49.17 47.60 48.78
    Resistance 2 (R2) 47.60 46.61 47.74 48.56
    Resistance 1 (R1) 46.57 46.00 47.09 46.83 48.35
    Pivot Point 45.00 45.00 45.26 45.14 45.00
    Support 1 (S1) 43.97 44.01 44.49 44.23 42.71
    Support 2 (S2) 42.40 43.40 42.54 42.50
    Support 3 (S3) 41.37 42.40 42.28
    Support 4 (S4) 41.63